TY  - RPRT
TI  - SARS-CoV-2 differs from SARS-CoV in the requirements for receptor expression and proteolytic activation to trigger cell-cell fusion and is not inhibited by Bromhexine
AU  - Hörnich, B. F.
AU  - Grosskopf, A. K.
AU  - Schlagowski, S.
AU  - Tenbusch, M.
AU  - Neipel, F.
AU  - Hahn, A. S.
PY  - 2020
DO  - 10.1101/2020.07.25.221135
UR  - https://www.biorxiv.org/content/10.1101/2020.07.25.221135v1
ID  - 10.1101/2020.07.25.221135
ER  -